Transplant Diagnostics: Technologies and Global Markets

  • ID: 3952276
  • Report
  • Region: Global
  • 186 Pages
  • BCC Research
15 % OFF
until Oct 31st 2018
1 of 6
The Global Transplant Diagnostics Market was Valued at $512.3 million in 2015 and is Estimated to Grow at a CAGR of 9.8% from 2016 Through 2021

FEATURED COMPANIES

  • Abbott Laboratories
  • Biofortuna Ltd.
  • Diasorin S.P.A.
  • Illumina Inc.
  • Luminex Corp.
  • Qiagen N.V.
  • MORE

This report provides:

  • An overview of the global markets for transplant diagnostics.
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Breakdowns of the market by application, end-users, and geography.
  • A look at how factors such as the high cost of instruments and limited insurance and reimbursement coverage available for transplant processes are expected to hamper the growth of the global transplant diagnostics market.
  • Evaluation of novel, future approaches in terms of biomarkers, bio-printing, and organoids.
  • Analyses of the market's dynamics: Drivers, restraints, opportunities.
  • Profiles of major players in the field.

The report covers the current market scenario for transplant diagnostics tests commercially available. These diagnostics tests are extensively used to study the compatibility between the donor and recipient in the process of organ transplantation. The report covers the segments mentioned below based on the revenue generated from the sales of transplant diagnostics products and services.

The following need to be taken into consideration:

  • The report considers the revenue generated by the sales of products, services and software used while conducting the transplant diagnostics test. These products can be kits, reagents, devices and software tools, among others.
  • The report considers revenue generated by pre-transplant as well as post-transplant tests.
  • The report does not consider the revenue generated by carrying out blood tests prior to transplant procedures (which is minor and done along with counseling itself).
  • Although the report is closely associated with the organ transplant market, it does not consider any organ transplant cost in any manner. It only considers diagnostics.
  • The periodic tests conducted post-transplant to determine the organ health in recipients’ bodies form a significant part of the revenue in the market.

The global transplant diagnostics market is segmented into two classes: nonmolecular assay and molecular assay technologies. Nonmolecular assay technologies are further segmented into serological assay and mixed lymphocyte culture (MLC) assay. The molecular assay technology market is segmented into polymerase chain reaction (PCR)-based and sequencing-based. The global transplant diagnostics technology market is further segmented on the basis of components for in-depth analysis of the market during the analysis period (2015-2021). The market study is detailed for the transplant diagnostics market based on end users as well as application area.

In-depth analysis of these segments is discussed in this report. The report also provides a detailed qualitative account of the market dynamics, technology trends, key strategies and regulatory scenario.

The market is segmented by region into North America, Europe, Asia-Pacific and ROW, including further division into key countries. Companies profiled in this report include Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Immucor Inc., Linkage Biosciences, Olerup SSP AB, Qiagen N.V., Thermo Fisher Scientific Inc. and Sigma-Aldrich, among others.

Intended Audience

The intended audience includes:

  • Transplant diagnostics tests, reagents, instruments, software manufacturers and
  • potential entrants.
  • Dealers, distributors and service providers of transplant diagnostics devices.
  • Healthcare service providers, private research institutes.
  • Government authorities, public service boards.
  • Research institutes, associations and academicians.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Biofortuna Ltd.
  • Diasorin S.P.A.
  • Illumina Inc.
  • Luminex Corp.
  • Qiagen N.V.
  • MORE

1: Introduction

  • Study And Objective
  • Scope Of Report
  • Intended Audience
  • Source Of Information And Methodology

2: Executive Summary

  • Executive Summary

3: Global Transplant Diagnostics Market Overview

  • Global Transplant Diagnostics Market Overview
  • HLA Typing In Transplant Diagnostics
  • Market Evolution And Innovations
  • Next-Generation Sequencing
  • Government Regulations, Medical Associations, Food And Drug Administration And International Regulatory Agencies
  • Demographics, Incidence And Prevalence Rates And Other Parameters Influencing Market Growth
  • Clinical Guidelines And Reimbursement Scenario
  • Technology Trends
  • U.S. HIV Organ Policy Equity (Hope) Act, 2013
  • Key Strategies
  • Market Dynamics

4: Transplant Diagnostics Market Analysis By Technologies

  • Molecular Assay Technologies
  • Nonmolecular Assay Technologies
  • Table 27 : Global Market For Transplant Diagnostics By Technologies, Through 2021

5: By Component

  • Instruments
  • Reagents And Consumables
  • Software And Services
  • Table 38 : Global Transplant Diagnostics Market By Component, Through 2021
  • Table 39 : Global Transplant Diagnostics Component Market By Region, Through 2021

6: Transplant Diagnostics Market Analysis By End User

  • Hospitals And Transplant Centers
  • Research Laboratories And Academic Institutions
  • Commercial Service Providers
  • Table 46 : Global Transplant Diagnostics Market By End User, Through 2021
  • Table 47 : Global Transplant Diagnostics Market By Region, Through 2021

7: Transplant Diagnostics Market Analysis By Applications

  • Research
  • Diagnostics
  • Table 52 : Global Transplant Diagnostics Market By Applications, Through 2021
  • Table 53 : Global Transplant Diagnostics Market By Region, Through 2021

8: Competitive Landscape

  • Competitive Landscape
  • Product Approvals And Launches
  • Mergers And Acquisitions
  • Agreements, Collaborations And Partnerships
  • Expansion
  • Investments

9: Regional Analysis

  • North America
  • Europe
  • Asia-Pacific
  • Rest Of The World
  • Table 68 : Global Transplant Diagnostics Market By Region, Through 2021

10: Patent Analysis

  • Introduction
  • United States
  • China
  • Europe

11: Company Profiles

  • Abbott Laboratories
  • Affymetrix Inc.
  • Astellas Pharma Inc.
  • Biofortuna Ltd.
  • Bio-Rad Laboratories
  • Caredx Inc.
  • Diasorin S.P.A.
  • F. Hoffmann-La Roche Ag
  • Fujirebio Europe N.V.
  • Gendx (Genome Diagnostics B.V.)
  • Illumina Inc.
  • Immucor Inc.
  • Linkage Biosciences
  • Luminex Corp.
  • Olerup SSP AB
  • Omixon Biocomputing Ltd.
  • Qiagen N.V.
  • Sigma-Aldrich Corp.
  • Thermo Fisher Scientific Inc.
  • Transplant Genomics Inc.

12: Appendix

  • Table 140 : List Of Patents Issued In Canada
  • Table 141 : List Of Patents Issued In China
  • Table 142 : List Of Patents In Issued Europe (Wo)
  • Table 143 : List Of Patents Issued In Europe
  • Table 144 : List Of Patents Issued By The European Patent Office (Epo)
  • Table 145 : List Of Patents Issued In Japan
  • Table 146 : List Of Patents Issued In Korea
  • Table 147 : List Of Patents Issued In The Russian Federation
  • Table 148 : List Of Patents Issued In Singapore

List Of Tables

Summary Table : Global Market For Transplant Diagnostics By Region, Through 2021
Table 1 : Types Of Organ Rejection Post-Transplant Procedures
Table 2 : Major Types Of Human Leukocyte Antigen
Table 3 : List Of Autoimmune Diseases Linked With HLA Types
Table 4 : List Of Few HLA Tests Commercially Available With Clinical Applications
Table 5 : Nucleic Acid Tests Approved By FDA
Table 6 : List Of CPT Codes For HLA Typing With Serological Testing
Table 7 : Maximum Fees For Pathology Laboratory, On And After January 1, 2015
Table 8 : Laboratory-Based Pre-Transplantation Biomarkers
Table 9 : Laboratory-Based Post-Transplantation Biomarkers (Acute Allograft Rejection)
Table 10 : Laboratory-Based Post-Transplantation Biomarkers (Chronic Allograft Damage)
Table 11 : Laboratory-Based Post-Transplantation Biomarkers (Allograft Accommodation)
Table 12 : FDA-Approved Biomarkers
Table 13 : Materials Used For Bioprinting
Table 14 : Application Of Organoids By Type
Table 15 : Strategic Development In Transplant Diagnostics Market, 2012-2016
Table 16 : FDA Approvals For Transplant Diagnostics Products, 2013-2016
Table 17 : Ce Approvals For Transplant Diagnostics Products, 2013-2016
Table 18 : New Product Launches In Transplant Diagnostics Market, 2013-2016
Table 19 : Companies Adopting M&A As A Developmental Strategy In Transplant Diagnostics Market
Table 20 : Mergers And Acquisitions In The Transplant Diagnostics Market, 2012-2016
Table 21 : Companies Adopting Agreements, Collaborations And Partnerships As A Developmental Strategy In Transplant Diagnostics Market, 2012-2016
Table 22 : List Of Companies That Adopted Agreements, Collaborations And Partnerships As Key Strategy, 2012-2016
Table 23 : Companies Adopting Expansion As A Key Strategy In Transplant Diagnostics Market, 2011-2016
Table 24 : Companies Adopting Investment As A Key Strategy In Transplant Diagnostics Market, 2013-2016
Table 25 : Chronic Diseases Listed By The Who, 2010-2013
Table 26 : Product Launches In Transplant Diagnostics Market, 2012-2016
Table 27 : Global Market For Transplant Diagnostics By Technologies, Through 2021
Table 28 : Global Market For Molecular Assays By Type, Through 2021
Table 29 : Global Market For Molecular Assay By Region, Through 2021
Table 30 : Global Market For Pcr-Based Molecular Assays By Region, Through 2021
Table 31 : Global Market For Sequencing-Based Molecular Assays By Region, Through 2021
Table 32 : Comparison Of Ngs Platforms
Table 33 : Global Market For Nonmolecular Assays By Type, Through 2021
Table 34 : Global Market For Nonmolecular Assays By Region, Through 2021
Table 35 : Global Market For Serological Assays By Region, Through 2021
Table 36 : Serological Types And Their Senstivity For Antibody Detection
Table 37 : Global Market For Mlc Assays, By Region, Through 2021
Table 38 : Global Transplant Diagnostics Market By Component, Through 2021
Table 39 : Global Transplant Diagnostics Component Market By Region, Through 2021
Table 40 : Global Transplant Diagnostics Instruments Market By Region, Through 2021
Table 41 : List Of Few Commercially Available Instruments For Transplant Diagnostics
Table 42 : Global Transplant Diagnostics Reagents And Consumables Market By Region, Through 2021
Table 43 : List Of Commercially Available Reagents For Transplant Diagnostics
Table 44 : Global Transplant Diagnostics Software And Services Market By Region, Through 2021
Table 45 : List Of Commercially Available Software And Services For Transplant Diagnostics
Table 46 : Global Transplant Diagnostics Market By End User, Through 2021
Table 47 : Global Transplant Diagnostics Market By Region, Through 2021
Table 48 : Global Transplant Diagnostics Hospitals And Transplant Centers Market By Region, Through 2021
Table 49 : Hospitals Providing HLA Typing And Transplant Services
Table 50 : Global Transplant Diagnostics Research Laboratories And Academic Institutions Market By Region, Through 2021
Table 51 : Global Transplant Diagnostics Commercial Service Providers Market By Region, Through 2021
Table 52 : Global Transplant Diagnostics Market By Applications, Through 2021
Table 53 : Global Transplant Diagnostics Market By Region, Through 2021
Table 54 : Global Transplant Diagnostics Research Market By Region, Through 2021
Table 55 : Survival Rates Of Patients
Table 56 : Global Transplant Diagnostics Market By Region, Through 2021
Table 57 : Key Competitive Strategies, 2012-2016
Table 58 : Product Approval And Launch Strategy By Company, 2013-2016
Table 59 : List Of Key Product Approvals And Launches Announced, 2013-2016
Table 60 : Merger And Acquisition Strategy By Companies, 2012-2016
Table 61 : List Of Key Mergers And Acquisitions Announced, 2013-2016
Table 62 : Agreements, Collaborations And Partnerships Strategy By Companies, 2012-2016
Table 63 : List Of Key Agreements, Collaborations And Partnerships Announced, 2012-2016
Table 64 : Expansion Strategies By Companies, 2011-2016
Table 65 : List Of Key Expansions Announced, 2011-2016
Table 66 : Investments Strategy By Companies, 2012-2016
Table 67 : List Of Key Investments Announced, 2012-2016
Table 68 : Global Transplant Diagnostics Market By Region, Through 2021
Table 69 : North American Transplant Diagnostic Market By Country, Through 2021
Table 70 : North American Transplant Diagnostic Market By End User, Through 2021
Table 71 : Commercial Transplant Diagnostics Products Approved By The FDA
Table 72 : Major Transplant Diagnostics Companies Based In The United States
Table 73 : European Transplant Diagnostic Market By Country, Through 2021
Table 74 : European Transplant Diagnostic Market By End User, Through 2021
Table 75 : Number Of Organ Donations In Spain By Type Of Donor, 2014
Table 76 : Number Of Organ Transplants In Spain By Type Of Organ, 2014
Table 77 : Number Of Organ Transplants In Italy By Type Of Organ, 2015
Table 78 : Number Of Organ Donations In Italy By Type Of Donor, 2015
Table 79 : Number Of Organ Donations In Turkey By Type Of Donor, 2015
Table 80 : Number Of Organ Transplants In Turkey By Type Of Organ, 2015
Table 81 : CE Approval For Transplant Diagnostics Market
Table 82 : Major European Players In Transplant Diagnostics Market
Table 83 : Asia-Pacific Transplant Diagnostic Market By Country, Through 2021
Table 84 : Asia-Pacific Transplant Diagnostic Market By End User, Through 2021
Table 85 : Number Of Organ Donations In Malaysia By Type Of Donor, 2013
Table 86 : Number Of Organ Transplants In Malaysia By Type Of Organ, 2013
Table 87 : Number Of Organ Donations In New Zealand By Type Of Donor, 2015
Table 88 : Number Of Organ Transplant Procedures In New Zealand By Type Of Organ, 2015
Table 89 : Transplant Diagnostics Company Present In Asia
Table 90 : ROW Transplant Diagnostics Market By Country, Through 2021
Table 91 : ROW Transplant Diagnostics Market By End User, Through 2021
Table 92 : Communicable And Noncommunicable Diseases Leading To Mortality In Brazil, 2014
Table 93 : Number Of Organ Donations In Brazil By Type Of Donor, 2015
Table 94 : Number Of Organ Transplant Procedures In Brazil By Type Of Organ, 2015
Table 95 : Age Adjusted Hospitalization Rate Due To Chronic Diseases In Israel, 2013
Table 96 : Number Of Organ Transplant Procedures In Israel By Type Of Organ, 2015
Table 97 : Number Of Organ Transplant Procedures In Israel By Type Of Organ, 2015
Table 98 : Number Of Organ Donations In Iran By Type Of Donor, 2015
Table 99 : Number Of Organ Transplant Procedures In Iran By Type Of Organ, 2015
Table 100 : Number Of Tissue Transplant Procedures In Iran By Type Of Tissue, 2015
Table 101 : Number Of Organ Donations In Saudi Arabia By Type Of Donor, 2015
Table 102 : Number Of Organ Transplant Procedures In Saudi Arabia By Type Of Organ, 2015
Table 103 : Patents Registered/Approved By Country, 2010-2016
Table 104 : Patents Registered/Approved In U.S. By Type Of Product, 2010-2016
Table 105 : Patents Registered/Approved In China By Type Of Product, 2010-2016
Table 106 : Patents Registered/Approved By Market Participants, 2010-2016
Table 107 : Patents Registered/Approved By Market Participants, 2010-2016
Table 108 : Patents Registered/Approved By Type Of Product, 2010-2016
Table 109 : Patents Related To Transplants
Table 110 : Recent Developments Of Abbott Laboratories
Table 111 : Abbott Laboratories Financials, 2013-2015
Table 112 : Recent Developments Of Affymetrix Inc.
Table 113 : Affymetrix Inc. Financials, 2012-2014
Table 114 : Astellas Pharma Inc. Financials, 2013-2015
Table 115 : Recent Developments Of Biofortuna Ltd.
Table 116 : Biofortuna Ltd. Financials, 2013-2015
Table 117 : Recent Developments Of Bio-Rad Laboratories
Table 118 : Bio-Rad Laboratories Financials, 2013-2015
Table 119 : Recent Developments Of Caredx Inc.
Table 120 : Caredx Inc. Financials, 2012-2014
Table 121 : Recent Developments Of Diasorin S.P.A.
Table 122 : Diasorin S.P.A. Financials, 2013-2015
Table 123 : Recent Developments Of F. Hoffmann-La Roche Ag
Table 124 : F. Hoffmann-La Roche Ag Financials, 2013-2015
Table 125 : Recent Developments Of Gendx
Table 126 : Recent Developments Of Illumina Inc.
Table 127 : Illumina Inc. Financials, 2013-2015
Table 128 : Recent Developments Of Immucor Inc.
Table 129 : Immucor Inc. Financials, 2013-2015
Table 130 : Recent Developments Of Linkage Biosciences
Table 131 : Recent Developments Of Luminex Corp.
Table 132 : Luminex Corp. Financials, 2013-2015
Table 133 : Recent Developments Of Olerup Ssp Ab
Table 134 : Recent Developments Of Qiagen N.V.
Table 135 : Qiagen N.V. Financials, 2013-2015
Table 136 : Sigma-Aldrich Financials, 2013-2015
Table 137 : Recent Developments Of Thermo Fisher Scientific Inc.
Table 138 : Thermo Fisher Scientific Financials, 2013-2015
Table 139 : Recent Developments Of Transplant Genomics Inc.
Table 140 : List Of Patents Issued In Canada
Table 141 : List Of Patents Issued In China
Table 142 : List Of Patents In Issued Europe (WO)
Table 143 : List Of Patents Issued In Europe
Table 144 : List Of Patents Issued By The European Patent Office (EPO)
Table 145 : List Of Patents Issued In Japan
Table 146 : List Of Patents Issued In Korea
Table 147 : List Of Patents Issued In The Russian Federation
Table 148 : List Of Patents Issued In Singapore

List Of Figures

Summary Figure : Global Market For Transplant Diagnostics By Region, 2015-2021
Figure 1 : Number Of Kidney Transplants In North America By Country, 2015
Figure 2 : Number Of Liver Transplants In North America By Country, 2015
Figure 3 : Number Of Organ Donations In North America By Type Of Donor, 2015
Figure 4 : Number Of Transplants By Type Of Organ In U.S., January 1988-June 2016
Figure 5 : Transplant Procedures Performed By Organ Type In U.S., January 1988-June 2016
Figure 6 : Number Of Transplants By Age Of Recipient In U.S., January 1988-June 2016
Figure 7 : Number Of Transplants By Type Of Donor In U.S., 2011-2015
Figure 8 : Number Of Organ Donations In U.S. By Type Of Donor, 2015
Figure 9 : Number Of Organ Transplant Procedures In U.S. By Type Of Organ, 2015
Figure 10 : Number Of Organ Donations In Canada By Type Of Donor, 2015
Figure 11 : Number Of Organ Transplant Procedures In Canada By Type Of Organ, 2015
Figure 12 : Number Of Organ Donations In Mexico By Type Of Donor, 2015
Figure 13 : Number Of Organ Transplant Procedures In Mexico By Type Of Organ, 2015
Figure 14 : Number Of Kidney Transplants In Europe By Country, 2015
Figure 15 : Number Of Liver Transplants In Europe By Country, 2015
Figure 16 : Number Of Organ Donations In Europe By Type Of Donor, 2015
Figure 17 : Hypertensive Diseases In Europe By Country, 2015
Figure 18 : Number Of Deaths Caused By Circulatory System Diseases In Europe By Country, 2012
Figure 19 : Number Of Organ Donations By Type Of Donor In Europe (France, Germany And United Kingdom), January 1988-June 2016
Figure 20 : Number Of Transplant Procedures By Type Of Organ In Europe (France, Germany And United Kingdom), January 1988-June 2016
Figure 21 : Number Of Kidney Transplants In Asia-Pacific By Country, 2015
Figure 22 : Number Of Liver Transplants In Asia-Pacific By Country, 2015
Figure 23 : Number Of Liver Transplants In Asia-Pacific By Country And Type Of Donor, 2015
Figure 24 : Number Of Organ/Tissue Transplant Procedures By Type Of Donor In Hong Kong, 2015
Figure 25 : Number Of Organ Transplants From Deceased Donors By Type Of Organ In Japan, 2015
Figure 26 : Number Of Organ Donations By Type Of Donor In Australia, 2015
Figure 27 : Number Of Organ Transplants By Type Of Organ In Australia, 2015
Figure 28 : Number Of Tissue Transplant Procedures By Type Of Tissue In Australia, 2015
Figure 29 : History Of The Hope Act, 2013
Figure 30 : Major Strategies Adopted By Players In The Transplant Diagnostics Market
Figure 31 : Global Population Aged 60 And Over By Region, 2015
Figure 32 : Waiting List For Organs In U.S. By Type Of Organ As Of July 15, 2016
Figure 33 : Waiting List For Organs In U.S. By Age Of Donor As Of July 15, 2016
Figure 34 : Workflow For Polymerase Chain Reaction
Figure 35 : Patents Registered/Approved By Country, 2010-2016
Figure 36 : Patents Registered/Approved In U.S. By Type Of Product, 2010-2016
Figure 37 : Patents Registered/Approved In China By Type Of Product, 2010-2016
Figure 38 : Patents Registered/Approved By Market Participants, 2010-2016
Figure 39 : Patents Registered/Approved By Type Of Product, 2010-2016

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Biofortuna Ltd.
  • Diasorin S.P.A.
  • Illumina Inc.
  • Luminex Corp.
  • Qiagen N.V.
  • MORE

Analyst’s Credentials

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, life sciences and chemicals. She has frequently delivered research services that contain strategic recommendations and top business strategies to help market players develop beneficial strategies. Yojana holds a MBA degree in marketing.

Note: Product cover images may vary from those shown
5 of 6
  • Abbott Laboratories
  • Affymetrix Inc.
  • Astellas Pharma Inc.
  • Biofortuna Ltd.
  • Bio-Rad Laboratories
  • Caredx Inc.
  • Diasorin S.P.A.
  • F. Hoffmann-La Roche Ag
  • Fujirebio Europe N.V.
  • Gendx (Genome Diagnostics B.V.)
  • Illumina Inc.
  • Immucor Inc.
  • Linkage Biosciences
  • Luminex Corp.
  • Olerup SSP AB
  • Omixon Biocomputing Ltd.
  • Qiagen N.V.
  • Sigma-Aldrich Corp.
  • Thermo Fisher Scientific Inc.
  • Transplant Genomics Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll